News
WINT
2.050
-0.24%
-0.005
Weekly Report: what happened at WINT last week (0310-0314)?
Weekly Report · 5h ago
Weekly Report: what happened at WINT last week (0303-0307)?
Weekly Report · 03/10 11:35
Windtree Therapeutics (WINT) Shares Are Volatile: What's Going On?
Benzinga · 03/04 14:38
Windtree Therapeutics announces notice of allowance from USPTO for istaroxime
TipRanks · 03/04 13:06
WINDTREE ANNOUNCES ISTAROXIME NOTICE OF ALLOWANCE FROM THE U.S. PATENT AND TRADEMARK OFFICE FOR ACUTE HEART FAILURE
Reuters · 03/04 13:00
Weekly Report: what happened at WINT last week (0224-0228)?
Weekly Report · 03/03 11:34
Windtree Therapeutics files patent in India for cardiac arrythmia therapy
TipRanks · 02/27 13:31
WINDTREE FILES ISTAROXIME CARDIOGENIC SHOCK AND PREVENTION OF ARRYTHMIAS PATENT FOR INDIA
Reuters · 02/27 13:06
Windtree Announces The Company Has Filed A National Phase Patent Application With The Indian Patent Office Claiming Priority To PCT/US2024/058923 Entitled, "ISTAROXIME AND DERIVATIVES THEREOF FOR PREVENTING OR REDUCING THE RISK OF ACUTE MYOCARDIAL ARRHYTHMIA."
Benzinga · 02/27 13:04
Weekly Report: what happened at WINT last week (0217-0221)?
Weekly Report · 02/24 11:34
Windtree Therapeutics Inc trading halted, news pending
TipRanks · 02/21 00:50
Windtree Therapeutics Announces Reverse Stock Split Approval
TipRanks · 02/18 13:28
*Windtree Therapeutics: Split Intended to Increase Price Per Shr of Company's Common Stk to Allow Co to Demonstrate Compliance With $1 Minimum Bid Price Requirement for Continued Listing on Nasdaq >WINT
Dow Jones · 02/18 13:06
*Windtree Therapeutics Announces 1-For-50 Reverse Stk Split >WINT
Dow Jones · 02/18 13:01
WINDTREE THERAPEUTICS INC - APPROVES 1-FOR-50 REVERSE STOCK SPLIT
Reuters · 02/18 13:00
Weekly Report: what happened at WINT last week (0210-0214)?
Weekly Report · 02/17 11:31
Windtree Therapeutics files for secondary stock offering
Seeking Alpha · 02/14 21:39
Windtree Therapeutics files to sell 40M shares of common stock for holders
TipRanks · 02/14 21:25
Biotech Alert: Searches spiking for these stocks today
TipRanks · 02/14 16:10
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 02/13 12:05
More
Webull provides a variety of real-time WINT stock news. You can receive the latest news about Windtree Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About WINT
More
Windtree Therapeutics, Inc. is a biotechnology company. The Company is focused on advancing early and late-stage therapies for critical conditions and diseases. The Company’s portfolio of product candidates includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, and preclinical precision aPKCi inhibitors that are being developed for potential in rare and broad oncology applications. Its lead product candidate, istaroxime, is a dual-acting agent being developed to increase blood pressure and improve cardiac function in patients with cardiogenic shock and to improve cardiac function in patients with acute heart failure (AHF) and reverse the hypotension and hypoperfusion associated with heart failure that deteriorates to cardiogenic shock. The Company also has a licensing business model with partnership out-licenses in place.